Emmet B Keeffe
Overview
Explore the profile of Emmet B Keeffe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
2136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin B, Ha N, Liu A, Trinh H, Nguyen H, Nguyen K, et al.
J Gastroenterol Hepatol
. 2013 Jan;
28(5):855-60.
PMID: 23278507
Background And Aim: Treatment end-point of therapy for patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) includes HBeAg seroconversion, which ranges from 15% to 22% after 1...
2.
Chaung K, Ha N, Trinh H, Garcia R, Nguyen H, Nguyen K, et al.
J Clin Gastroenterol
. 2012 Sep;
46(10):865-70.
PMID: 22941429
Background: The primary treatment endpoint for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B is HBeAg seroconversion; however, data on the durability of response are inconsistent. Goals: Our goal was...
3.
Ha N, Ha N, Ahmed A, Ayoub W, Daugherty T, Chang E, et al.
Cancer Causes Control
. 2012 Jan;
23(3):455-62.
PMID: 22258434
The majority of data on risk factors (RFs) for hepatocellular carcinoma (HCC) comes from studies involving populations without underlying liver disease. It is important to evaluate RFs for HCC in...
4.
Lee M, Keeffe E
Gastroenterol Clin North Am
. 2011 Sep;
40(3):495-505.
PMID: 21893270
The goal of antiviral treatment of chronic hepatitis B is to prevent the complications of cirrhosis, hepatic decompensation, HCC, and death. Because these clinical outcomes may take a long period...
5.
Gonzalez S, Keeffe E
Gastroenterol Hepatol (N Y)
. 2011 Aug;
7(6):366-73.
PMID: 21869868
Genome-wide association studies have recently identified single nucleotide polymorphisms in proximity to the interleukin-28B (IL-28B) gene that can predict sustained virologic response (SVR) in patients with chronic hepatitis C virus...
6.
Huda A, Newcomer R, Harrington C, Blegen M, Keeffe E
Liver Transpl
. 2011 Aug;
18(1):89-99.
PMID: 21837745
The goal of liver transplantation (LT) is to maximize the length and quality of a patient's life and facilitate his or her return to full productivity. The aims of this...
7.
8.
Wong C, Trinh H, Yip B, Nguyen H, Garcia R, Ahmed A, et al.
J Clin Gastroenterol
. 2011 Jul;
45(10):900-5.
PMID: 21778896
Background: Combination therapy for chronic hepatitis B virus (HBV) infection is recommended for patients with antiviral resistance (AVR) or partial response (PR) to earlier antiviral therapy; however, data on outcomes...
9.
Gonzalez S, Keeffe E
Clin Liver Dis
. 2011 Jun;
15(2):297-306, vii-x.
PMID: 21689614
Early diagnosis of hepatocellular carcinoma (HCC) has a significant impact on survival by implementation of effective treatment strategies, including hepatic resection, locoregional ablative therapy, and liver transplantation. The use of...
10.